论文标题
通过基于CT的集合AI算法预测胰腺癌的风险
Predicting the risk of pancreatic cancer with a CT-based ensemble AI algorithm
论文作者
论文摘要
目标:胰腺癌是一种致命的疾病,难以诊断,通常导致预后不良和高死亡率。开发人工智能(AI)算法,以准确而普遍地预测各种胰腺癌的早期癌症风险非常重要。我们提出了一种合奏AI算法,以预测具有非对比CT的各种胰腺病变的普遍癌症风险。方法:我们的算法通过证据推理(ER)技术结合了放射线方法和支持张量机(STM),以构建称为RADSTM-ER的二进制分类器。 RADSTM-ER利用了STM从CTS自动学习的放射线和学习功能中使用的手工制作的功能,以呈现出更好的病变特征。该患者队列由135例病理诊断结果组成,其中97名患者患有恶性病变。将27例患者随机选择为独立的测试样本,其余患者被用于5倍的交叉验证实验中,以确认超参数,选择最佳手工制作的特征并训练模型。结果:RADSTM-ER实现了独立的测试结果:接收器工作特性曲线下的面积为0.8951,精度为85.19%,灵敏度为88.89%,特异性为77.78%,正预测值为88.89%,负预测值为77.78%。结论:这些结果比五种实验放射学家的诊断性能更好,这是四种常规AI算法,最初证明了非基于CT CT的RADSTM-ER在各种胰腺病变中的癌症风险预测中的潜力。
Objectives: Pancreatic cancer is a lethal disease, hard to diagnose and usually results in poor prognosis and high mortality. Developing an artificial intelligence (AI) algorithm to accurately and universally predict the early cancer risk of all kinds of pancreatic cancer is extremely important. We propose an ensemble AI algorithm to predict universally cancer risk of all kinds of pancreatic lesions with noncontrast CT. Methods: Our algorithm combines the radiomics method and a support tensor machine (STM) by the evidence reasoning (ER) technique to construct a binary classifier, called RadSTM-ER. RadSTM-ER takes advantage of the handcrafted features used in radiomics and learning features learned automatically by the STM from the CTs for presenting better characteristics of lesions. The patient cohort consisted of 135 patients with pathological diagnosis results where 97 patients had malignant lesions. Twenty-seven patients were randomly selected as independent test samples, and the remaining patients were used in a 5-fold cross validation experiment to confirm the hyperparameters, select optimal handcrafted features and train the model. Results: RadSTM-ER achieved independent test results: an area under the receiver operating characteristic curve of 0.8951, an accuracy of 85.19%, a sensitivity of 88.89%, a specificity of 77.78%, a positive predictive value of 88.89% and a negative predictive value of 77.78%. Conclusions: These results are better than the diagnostic performance of the five experimental radiologists, four conventional AI algorithms, which initially demonstrate the potential of noncontrast CT-based RadSTM-ER in cancer risk prediction for all kinds of pancreatic lesions.